China caprolactam corrects after peak on softer crude

China’s caprolactam prices surged up to 54.5 per cent between Jan–Apr 2026, driven by restocking, geopolitical tensions, and crude spikes, before correcting on easing conflict signals.
Despite volatility, prices remain elevated, with near-term direction tied to crude trends and Middle East developments, impacting Nylon-6 and textile costs.